Vialwirebiotech, curated
July 22, 2026, 10:14 PM
May 27, 2026
- 5:11 PM · TechCrunch5:11 PMTriomics nabs $22M to bring oncology-specific AI to cancer centers — TechCrunch
- 2:43 PM · BioPharma Dive2:43 PMVerge, following trial failure, rebrands its AI drug discovery ambitions — BioPharma Dive
- 2:09 PM · BioPharma Dive2:09 PMFDA delays decision on AstraZeneca breast cancer pill — BioPharma Dive
- 12:07 PM · BioPharma Dive12:07 PMCardio drugmaker Kardigan plans to go public — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMApogee orbiting big AD market as Apex phase II data land — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMKailera’s three-pronged obesity shot shows promise in early trial — BioPharma Dive
- 9:00 AM · SCMP — Tech
- 9:00 AM · BioWorld9:00 AMCoultreon Biopharma discloses new p53 Y220C mutant stabilizers — BioWorld
- 9:00 AM · BioWorld9:00 AMCircio and Aavigen to collaborate on targeted cardiac AAVs — BioWorld
- 9:00 AM · BioWorld9:00 AMKLS-3021 suppresses tumors and induces immune memory in TNBC — BioWorld
- 9:00 AM · BioWorld9:00 AMKallyope reports new GRPR agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMONYX-101 restores COL4A5 expression in X-linked Alport syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMAlterome Therapeutics patents new GTPase KRAS inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMCYPS-317 exerts durable immunomodulation in psoriasis — BioWorld
- 9:00 AM · BioWorld9:00 AMTreeline Biosciences prepares new Bcl-xl degraders — BioWorld
- 9:00 AM · BioWorld9:00 AMNewcelx submits pre-IND package for NCEL-101 to FDA — BioWorld
- 9:00 AM · BioWorld9:00 AMNew GLP-1R agonists described in MSD patent — BioWorld
- 9:00 AM · BioWorld9:00 AMBiomunex enters AI partnerships to advance cancer immunotherapies — BioWorld
- 7:34 AM · Drug Discovery World7:34 AMWatch now: The first GMP-validated AVA test using Oxford Nanopore sequencing — Drug Discovery World
- 6:30 AM · Drug Discovery World6:30 AMNICE recommends lung cancer combination therapy — Drug Discovery World
- 5:32 AM · Pharmaceutical Technology5:32 AMAutobahn’s elunetirom receives FDA fast track designation to treat adjunctive bipolar — Pharmaceutical Technology
- 5:03 AM · Pharmaceutical Technology5:03 AMSK bioscience and VECOL partner on Colombia vaccine manufacturing initiative — Pharmaceutical Technology
May 26, 2026
- 8:30 PM · SCMP — Tech8:30 PMInsilico teams up with US firm to build AI models predicting disease decades ahead — SCMP — Tech
- 12:00 PM · BioWorld12:00 PMLilly buys three vaccine makers; PCSK9 base editor shows promise — BioWorld
- 12:00 PM · BioWorld12:00 PMKennedy offers emergency immunity for use of MCM in hantavirus — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA adcom to consider next iteration of COVID-19 vaccines — BioWorld
- 12:00 PM · BioWorld12:00 PMAhR you ready for this? A new (or not-so-new) approach in UC — BioWorld
- 11:42 AM · Pharmaceutical Technology11:42 AMThinning revenues: inside the $14bn Eliquis patent cliff — Pharmaceutical Technology
- 11:24 AM · Pharmaceutical Technology11:24 AMEMA recommends approvals for both oral and high-dose pen of Wegovy — Pharmaceutical Technology
- 10:01 AM · NYT — Science10:01 AMEli Lilly to Buy 3 Vaccine Developers — NYT — Science
- 10:00 AM · Drug Discovery World10:00 AMEnzyme inhibitor shows early evidence of treating sarcoma — Drug Discovery World
- 9:20 AM · Drug Discovery World9:20 AMSingle-shot gene therapy could cut cholesterol by 62% — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMUSP1 inhibitors detailed in Yantai New Drug Creation patent — BioWorld
- 9:00 AM · BioWorld9:00 AMCocrystal Pharma discovers new pan-viral inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMBiotle’s FcRn inhibitor BTL-203 cleared for clinic in China — BioWorld
- 9:00 AM · BioWorld9:00 AMKunshan Xinyunda Biotechnology synthesizes new ADAM9-targeting ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMAddition Therapeutics presents approach for Fabry disease — BioWorld
- 9:00 AM · BioWorld9:00 AMCavalon Therapeutics and Northwestern patent new Cav1.3 blockers — BioWorld
- 9:00 AM · BioWorld9:00 AMMSD divulges new KLKB1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMGemma Biotherapeutics’ GB-703 shows promise for DMD — BioWorld
- 9:00 AM · BioWorld9:00 AMConvalife Pharmaceuticals discloses new CD38 inhibitors — BioWorld
- 4:16 AM · Pharmaceutical Technology4:16 AMPierre Fabre’s Braftovi gains CHMP positive opinion for mCRC — Pharmaceutical Technology